Literature DB >> 729618

An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).

D Findlay, J R Lawrence.   

Abstract

An established method for collecting uncontaminated parotid saliva has been applied to assessment of salivary flow rate. Following single doses of 0.3 mg clonidine and 1.0 mg tiamenidine (HOE 440) changes in blood pressure, heart rate, sedation (assessed by a self-rating scale) and salivary flow were followed in nine normal subjects. Both drugs produced a fall in systolic and diastolic blood pressure, sedation, depression of salivary flow and a lowering of heart rate. These changes were maximal between 2 and 6 h and were more marked after clonidine than after tiamenidine. As tiamenidine 1.0 mg did not produce a hypotensive effect equivalent to clonidine 0.3 mg direct comparison of side-effects attributable to these agents proved difficult. The evidence suggests, however, that tiamenidine would cause sedation and reduction in salivary flow comparable to clonidine if given in an equivalent hypotensive dose.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 729618     DOI: 10.1007/bf00560455

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Clinical pharmacology and pharmacokinetics of clonidine.

Authors:  C T Dollery; D S Davies; G H Draffan; H J Dargie; C R Dean; J L Reid; R A Clare; S Murray
Journal:  Clin Pharmacol Ther       Date:  1976-01       Impact factor: 6.875

2.  Methods for collecting individual components of mixed saliva: the relevance to clinical pharmacology.

Authors:  K W Stephen; C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

3.  Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.

Authors:  D S Davies; A M Wing; J L Reid; D M Neill; P Tippett; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1977-05       Impact factor: 6.875

4.  The central hypotensive effect of clonidine. Studies in tetraplegic subjects.

Authors:  J L Reid; L M Wing; C J Mathias; H L Frankel; E Neill
Journal:  Clin Pharmacol Ther       Date:  1977-04       Impact factor: 6.875

5.  Tiamenidine (Hoe 440), a new antihypertensive substance.

Authors:  E Lindner; J Kaiser
Journal:  Arch Int Pharmacodyn Ther       Date:  1974-10

6.  Comparison of clonidine and methyldopa on blood pressure and side effects in hypertensive patients.

Authors:  M R Putzeys; S W Hoobler
Journal:  Am Heart J       Date:  1972-04       Impact factor: 4.749

7.  Some observations on the inhibition of salivation by St 155 [2-(2,6-dichlorophenylamine)-2-imidazoline hydrochloride, Catapres, Catapresan].

Authors:  M J Rand; M Rush; J Wilson
Journal:  Eur J Pharmacol       Date:  1969-01       Impact factor: 4.432

8.  Central nervous system depressant actions of clonidine and UK-14,304: partial dissociation of EEG and behavioural effects.

Authors:  H Ashton; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

  8 in total
  3 in total

Review 1.  Xerostomia and hyposalivation: causes, consequences and treatment in the elderly.

Authors:  T O Närhi; J H Meurman; A Ainamo
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

2.  Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males.

Authors:  K Weerasuriya; E Shaw; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Changes in blood pressure, heart rate, and sympathetic activity on abrupt withdrawal of tiamenidine (HOE 440) in essential hypertension.

Authors:  B C Campbell; H L Elliott; C A Hamilton; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.